Scope of the Study
The global Codeine market is expected to witness high demand in the forecasted period due to the alarming increase in the incidence of orthopedic diseases & chronic pain. Codeine is part of a group of drugs known as opioids. Opioids interact with opioid receptors in the brain and elicit a range of responses within the body, from feelings of pain relief to relaxation, pleasure, and contentment. Codeine is used to provide relief from a number of conditions, including mild to moderate pain, severe pain, dry irritating cough, diarrhea, and cold and flu. In Australia, Canada, New Zealand, Sweden, the United Kingdom, the United States, and many other countries, codeine is regulated under various narcotic control laws.
The market study is being classified by Type (Extracted from Opium and Synthesized by Morphine), by Application (Pain Management, Cough Treatment and Diarrhea Treatment) and major geographies with country level break-up.
Purdue Pharma (United States), Sanofi (France), Pfizer (United States), Janssen Pharmaceuticals (Belgium), Endo Pharmaceuticals, Inc (United States), Actavis Plc (United States), Egalet (United States), Sun Pharmaceuticals (India) and Boehringer Ingelheim GmbH (Germany) are some of the key players profiled in the study.
The companies are exploring the market by adopting expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to avail a competitive advantage through combined collaborations. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Codeine market throughout the predicted period.
AdvanceMarketAnalytics has segmented the market of Global Codeine market by Type, Application and Region.
On the basis of geography, the market of Codeine has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). North America region held largest market share in the year 2018. Europe on the other hand stood as second largest market due to the presence of key companies into the region and high technological advancement. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- The Rise in Disposable Income and Surge in Global Geriatric Population
- Increasing Investment in Healthcare Sectors
- The Increasing Focus on the Abuse-Deterrent Formulation (ADF)
- The Growing Prevalence of Orthopedic Diseases and Chronic Pain
- The Growing Concern Related to the Legalization of Cannabis
- Increasing Issues Related to Prescription Drug Abuse
- The Increase in Consumption of Opioid Analgesic for Pain Management in Developing Countries
- Rising Demand due to Ongoing Research and Developments in the Treatment Area
- The Stringent Government Regulation Associated with Codeine
"In Canada, the use of opioids, including codeine, is currently regulated by the Controlled Drugs and Substances Act. Due to the potential of developing dependence among users, most codeine products are available by prescription only. Low-dose codeine (doses lower than or equal to 30 mg per tablet or 2 mg per milliliter [mL]), however, can be sold without a prescription if used in combination with at least two other medications. These are available as ‘over the counter’ (OTC) medications but are usually stored behind the pharmacy counter. In Manitoba, low-dose codeine products are available only by prescription."
Key Target AudienceCodeine Manufactures, Codeine Suppliers, Codeine Distributors, Government Regulatory Bodies, Government Research Organizations, Private Research Organizations and Others
Customization in the Report Available:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase